Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Agency
National Institutes of Health
Deadline
Not specified
Total Funding
Not specified
Expected Awards
Not specified
Minimum Award
Not specified
Maximum Award
Not specified
Posted Date
Sep 22, 2026
Opportunity Number
RFA-NS-28-009
Description
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting the conduct of scientific research utilizing data from intermediate-size patient population expanded access protocols for ALS ("intermediate expanded access protocol for ALS", see Expanded Access Categories for Drugs (Including Biologics)). Eligible intermediate expanded access protocols for ALS should: 1) provide access to an investigational drug or biological product for people with ALS, and 2) generate data to support research on the prevention, diagnosis, mitigation, treatment, or cure of ALS. The scientific research goal(s) informed by these data could include the investigational drug's or biological product's effect on biomarkers related to the pathophysiology of ALS or target engagement, the collection of safety or outcome information, such as survival or other significant medical events (e.g., hospitalization or need for ventilatory support), or patient experience data that are not specifically tied to assessing efficacy. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects.
Eligible Applicants
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
- County governments
- City or township governments
- Small businesses
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Special district governments
- Native American tribal organizations (other than Federally recognized tribal governments)
Data snapshot from September 28, 2026. For the most current information, view the opportunity on Grants.gov.
Interested in this opportunity?
Grants Republic can help you build a competitive proposal. With 38 years of combined experience and $440M+ in awarded funding, we know what reviewers look for.
Discuss This Opportunity